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The century’s end has inspired many of us to try our hand
as futurists. This year, marking the end of the century and
the beginning of the College’s second half-century, has
provided the American College of Cardiology (ACC) with
numerous opportunities to look at what the College has
done so far and to analyze how the challenges of the next
half-century should be approached.
In December 1999, the College’s past presidents, officers,
trustees, and governors gathered with renowned futurists in
New York City to conduct a Forum on the Future, an
opportunity to examine the delivery of quality cardiovascular
care in the twenty-first century. Next month, JACC will
feature the results of the forum, a consensus document on
cost, technology, demographics, and the College’s response
to changes in these areas. To set the stage for the publica-
tion of this important document, I offer for consideration
my thoughts on the future, which were published as an
Afterword in the ACC commemorative book, American
College of Cardiology: A Visual History, 1949 –1999 (1):
“Although predicting is perilous, not predicting is even
more perilous. It leaves us unprepared for the changes
going on right under our noses, confronts us with
recurrent surprises and makes us reactors instead of
agents of change.”
—Jerome Kassirer
Predicting the next hundred years is relatively simple;
predicting the next 10 is very difficult. In 1980, I was asked
to predict the next 10 years of our field and then was held
accountable in 1990 when I was asked to give a talk (called
“Back to the Future: Part II”) summarizing the success of
my predictions. My range finding was off: two of the
predictions have only begun to occur 18 years later. Un-
daunted as to prediction, I do believe there will be changes
in three important areas in the next millennium: in our
practice, in our physicians, and in our health care.
Our practice will become more focused on prevention.
The prevention of coronary artery disease and stroke by
manipulation of molecular and mechanical factors is likely
to precede the prevention of cardiomyopathies, heart failure,
and congenital heart disease. Molecular diagnosis will pre-
cede molecular treatment; nonetheless, conventional treat-
ments will be more productive, with earlier warning pro-
vided by molecular diagnosis.
Long before these more global advances, incremental
advances will move toward noninvasive assessment of the
coronary circulation, minimally invasive approaches to cor-
onary artery diseases, and application of molecular tech-
niques to enable focused regeneration of myocardium and
specialized conducting tissue.
Transplantation immunology and ethics will need to
advance significantly to address issues of animal organs or
growth of human tissue in vitro. Just as restenosis has
spawned new research into latrogenic disease, so will every
new treatment require investigation and treatment of its
unintended consequences.
Our physicians will return to more cognitive pursuits as
preventive strategies increase. In the short-to-medium term,
however, there will be a need for the clinical molecular
biologist (perhaps cum-interventionalist) who will translate
the new knowledge and apply it more rapidly than ever
before. Our physicians will return to their traditional role as
patient advocate; the preoccupation with cost will diminish.
Cost will be only one parameter: only those diagnostic and
therapeutic regimens that significantly improve patient care
at a reasonable cost will survive.
Our health care system will change. The Baby Boom
generation is rapidly approaching the time when illness will
visit them. This influx of an aging population will increase
the overall cost of health care. Also, perhaps less obviously,
the need for performance improvement and improved qual-
ity will lead to an increase in the cost of care. Americans,
when presented with quality data that they understand, will
choose the best health care available. This need for quality
will cause a return to a more appropriate balance of specialty
care than has been espoused in the past few years. The
development of new technology, including molecular diag-
nostics and therapeutics, will improve the quality of life but
will be expensive in both its development and practice. New
technology will prolong life but will still require some degree
of health care services. This increase in cost will not be
borne easily by the current private payers for health care and
is likely to result in less coverage and more disenfranchise-
ment of greater segments of the population. Traditionally,
the U.S. has provided health care coverage for those least
able to pay, beginning with the elderly and the disabled and
extending to the poor. In the future, it will be the middle
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class who will be disenfranchised. The ultimate solution will
require health care coverage for all Americans.
One future prediction is certain: the ACC will continue to
be the most relevant provider of medical education, perfor-
mance improvement, and advocacy for those concerned with
cardiovascular disease. If even a few of the changes I have
outlined come to fruition, the knowledge deficit will deepen,
and the role of the cardiovascular specialist in helping to shape
the health care system will become even more pronounced.
The ACC will be the agent for the practitioner in these areas.
The College, building on its current and future membership,
will be even stronger after its second 50 years than it is even
after its amazing first 50 years.
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